Figure 3
Figure 3. Foxp3 induction in CD4+CD25− T cells in biopsy specimens of B-cell NHL. Foxp3 expression was examined in CD4+CD25− T cells stimulated with OKT3 or OKT3/anti-CD28 Ab (A) (n = 10) or with in vitro–generated DCs pulsed with or without super-Ag TSST-1 (B) (n = 3). (C) Foxp3 expression in CD4+CD25− or CD8+ T cells upon activation. CFSE was used to monitor activation and proliferation (n = 6). Percentages indicate number of proliferated CD8+ T cells (CFSEdim) of just the CD8+ cell population. (D) CD25 and Foxp3 expression determined at specific day after activation in intratumoral CD4+CD25− T cells in B-cell NHL (n = 4).

Foxp3 induction in CD4+CD25 T cells in biopsy specimens of B-cell NHL. Foxp3 expression was examined in CD4+CD25 T cells stimulated with OKT3 or OKT3/anti-CD28 Ab (A) (n = 10) or with in vitro–generated DCs pulsed with or without super-Ag TSST-1 (B) (n = 3). (C) Foxp3 expression in CD4+CD25 or CD8+ T cells upon activation. CFSE was used to monitor activation and proliferation (n = 6). Percentages indicate number of proliferated CD8+ T cells (CFSEdim) of just the CD8+ cell population. (D) CD25 and Foxp3 expression determined at specific day after activation in intratumoral CD4+CD25 T cells in B-cell NHL (n = 4).

Close Modal

or Create an Account

Close Modal
Close Modal